Vascular endothelial growth factor A (VEGF-A) is a potent proangiogenic cytokine elevated in patients with peripheral artery disease (PAD). A new study links impaired vascular regrowth in PAD to increased expression of an antiangiogenic splice variant of VEGF-A.
Your institute does not have access to this article
Relevant articles
Open Access articles citing this article.
-
VEGF-A splice variants bind VEGFRs with differential affinities
Scientific Reports Open Access 02 September 2020
Access options
Subscribe to Journal
Get full journal access for 1 year
$59.00
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

Katie Vicari/Nature Publishing Group
References
Annex, B.H. Nat. Rev. Cardiol. 10, 387–396 (2013).
Kikuchi, R. et al. Nat. Med. 20, 1464–1471 (2014).
Shimamura, M., Nakagami, H., Koriyama, H. & Morishita, R. Biomed. Res. Int. 2013, 186215 (2013).
Makin, A.J., Chung, N.A.Y., Silverman, S.H. & Lip, G.Y.H. Clin. Sci. 104, 397–404 (2003).
Bates, D.O. et al. Cancer Res. 62, 4123–4131 (2002).
Peiris-Pagès, M. Cell Adh. Migr. 6, 561–568 (2012).
Volpi, N. et al. Mediators Inflamm. 2013, 219313 (2013).
Jones, W.S. et al. Vasc. Med. 17, 94–100 (2012).
Kikuchi, A., Yamamoto, H., Sato, A. & Matsumoto, S. Acta Physiol. (Oxf.) 204, 17–33 (2012).
Stefater, J.A. III et al. Nature 474, 511–515 (2011).
Ouchi, N. et al. Science 329, 454–457 (2010).
Merdzhanova, G. et al. Oncogene 29, 5392–5403 (2010).
Rieder, D. et al. Cell. Mol. Life Sci. 71, 1741–1759 (2014).
Yoshida, K. et al. Nature 478, 64–69 (2011).
Nowak, D.G. et al. J. Cell Sci. 121, 3487–3495 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Boucher, J., Bautch, V. Antiangiogenic VEGF-A in peripheral artery disease. Nat Med 20, 1383–1385 (2014). https://doi.org/10.1038/nm.3767
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3767
Further reading
-
VEGF-A splice variants bind VEGFRs with differential affinities
Scientific Reports (2020)
-
Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma
Applied Microbiology and Biotechnology (2018)